Share Price and Basic Stock Data
Last Updated: January 9, 2026, 3:53 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sagar Cements Ltd operates in the cement industry, with a market capitalization of ₹2,834 Cr and a share price of ₹217. The company reported a significant increase in sales, rising from ₹1,597 Cr in FY 2022 to ₹2,230 Cr in FY 2023, reflecting a robust growth trajectory. The trailing twelve months (TTM) sales stood at ₹2,494 Cr, indicating a slight decline in FY 2025 to ₹2,258 Cr. Quarterly sales figures also demonstrated variability, with the highest quarterly sales of ₹709 Cr recorded in Mar 2024, while sales for Jun 2025 were ₹671 Cr. This fluctuation may indicate seasonal demand patterns or operational challenges. The operating profit margin (OPM) remained relatively low, peaking at 13% in Dec 2023 but averaging only around 9% across recent quarters, suggesting ongoing cost pressures. Overall, while Sagar Cements has shown growth in revenues, the fluctuating quarterly performance and low OPM highlight challenges in maintaining profitability.
Profitability and Efficiency Metrics
Sagar Cements’ financial performance indicates significant challenges, particularly in profitability metrics. The company reported a net loss of ₹164 Cr for FY 2025, with a negative net profit margin of -9.59%. This represents a deterioration compared to the previous year’s net loss of ₹52 Cr. The operating profit stood at ₹141 Cr for FY 2025, down from ₹247 Cr in FY 2024, reflecting a declining trend in operational efficiency. The interest coverage ratio (ICR) of 0.86x indicates that the company’s earnings are insufficient to cover its interest expenses, a concerning sign for financial stability. Furthermore, the return on equity (ROE) is low at 10.3%, while return on capital employed (ROCE) declined to -2.29% in FY 2025. These figures suggest that Sagar Cements faces significant challenges in translating sales into profits, which could limit its ability to reinvest in growth or return value to shareholders.
Balance Sheet Strength and Financial Ratios
Sagar Cements’ balance sheet reveals a complex financial structure characterized by considerable borrowings of ₹1,640 Cr against reserves of ₹1,656 Cr. This results in a total debt-to-equity ratio of 0.82x, which is within the sector’s typical range but raises concerns regarding financial leverage. The current ratio of 0.58x and quick ratio of 0.35x indicate liquidity challenges, suggesting that the company may struggle to meet short-term obligations. The book value per share, reported at ₹131.81 for FY 2025, reflects a decline from previous years, highlighting the erosion of shareholder value. Additionally, the cash conversion cycle (CCC) of -225 days indicates that Sagar Cements efficiently manages its working capital, as it receives cash from its sales before it needs to pay its suppliers. While the company shows strengths in cash management, the overall balance sheet presents risks due to high leverage and declining liquidity ratios.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sagar Cements reveals a stable but cautious investor base. Promoters hold 48.33% of the company, which reflects a strong commitment from the founding members. However, foreign institutional investors (FIIs) hold only 2.84%, indicating limited foreign interest, while domestic institutional investors (DIIs) account for 17.39%, suggesting moderate confidence from local institutions. The public holds 31.42%, and the number of shareholders stood at 31,977 as of Sep 2025, indicating a relatively stable retail investor base. The fluctuations in shareholding, particularly the decline in FII participation from 3.99% in Dec 2022 to 2.84% in Dec 2023, may raise concerns about market sentiment and investor confidence. While the promoter stake provides some stability, the low FII interest could limit growth potential and affect stock liquidity.
Outlook, Risks, and Final Insight
The outlook for Sagar Cements hinges on its ability to navigate several risks and capitalize on its strengths. Key strengths include its efficient cash conversion cycle and strong promoter support, which could provide a foundation for future growth. However, significant risks include the ongoing profitability challenges, high leverage, and liquidity constraints, which pose threats to financial stability. The company’s declining net profit margins and high interest coverage ratio signal the need for operational improvements and cost management strategies. Additionally, external factors such as fluctuating cement prices and changes in demand could impact future performance. In a scenario where operational efficiency improves and market conditions stabilize, Sagar Cements could potentially recover and enhance shareholder value. Conversely, continued losses and liquidity pressures may necessitate strategic restructuring or capital infusion to sustain operations.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,55,501 Cr. | 12,064 | 13,102/10,048 | 48.5 | 2,444 | 0.64 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,579 Cr. | 1,082 | 1,209/788 | 133 | 322 | 0.18 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 14,757 Cr. | 476 | 486/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,965 Cr. | 222 | 309/196 | 29.6 | 74.4 | 0.45 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 38,091.19 Cr | 1,939.18 | 37.64 | 573.47 | 0.54% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 475 | 576 | 622 | 540 | 587 | 669 | 709 | 561 | 475 | 564 | 658 | 671 | 602 |
| Expenses | 469 | 528 | 583 | 509 | 527 | 582 | 641 | 514 | 455 | 526 | 621 | 549 | 551 |
| Operating Profit | 6 | 48 | 39 | 30 | 60 | 87 | 68 | 47 | 20 | 38 | 37 | 121 | 51 |
| OPM % | 1% | 8% | 6% | 6% | 10% | 13% | 10% | 8% | 4% | 7% | 6% | 18% | 9% |
| Other Income | 15 | 14 | 181 | 4 | 18 | 4 | 44 | 8 | 5 | 5 | -24 | 4 | 4 |
| Interest | 50 | 51 | 52 | 44 | 47 | 49 | 45 | 46 | 46 | 48 | 47 | 47 | 46 |
| Depreciation | 38 | 40 | 42 | 50 | 51 | 57 | 56 | 56 | 58 | 59 | 58 | 55 | 56 |
| Profit before tax | -68 | -29 | 126 | -59 | -20 | -15 | 10 | -48 | -79 | -64 | -93 | 24 | -47 |
| Tax % | -36% | -19% | 30% | -29% | -48% | -28% | -13% | -32% | -28% | -15% | -21% | 69% | -5% |
| Net Profit | -44 | -24 | 88 | -42 | -11 | -10 | 12 | -32 | -57 | -54 | -73 | 7 | -44 |
| EPS in Rs | -2.80 | -1.42 | 6.92 | -3.05 | -0.64 | -0.62 | 1.01 | -2.17 | -4.25 | -4.21 | -5.41 | 0.09 | -3.24 |
Last Updated: December 29, 2025, 7:35 am
Below is a detailed analysis of the quarterly data for Sagar Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 602.00 Cr.. The value appears to be declining and may need further review. It has decreased from 671.00 Cr. (Jun 2025) to 602.00 Cr., marking a decrease of 69.00 Cr..
- For Expenses, as of Sep 2025, the value is 551.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 549.00 Cr. (Jun 2025) to 551.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Jun 2025) to 51.00 Cr., marking a decrease of 70.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Jun 2025) to 9.00%, marking a decrease of 9.00%.
- For Other Income, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Interest, as of Sep 2025, the value is 46.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.00 Cr. (Jun 2025) to 46.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 55.00 Cr. (Jun 2025) to 56.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Jun 2025) to -47.00 Cr., marking a decrease of 71.00 Cr..
- For Tax %, as of Sep 2025, the value is -5.00%. The value appears to be improving (decreasing) as expected. It has decreased from 69.00% (Jun 2025) to -5.00%, marking a decrease of 74.00%.
- For Net Profit, as of Sep 2025, the value is -44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Jun 2025) to -44.00 Cr., marking a decrease of 51.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -3.24. The value appears to be declining and may need further review. It has decreased from 0.09 (Jun 2025) to -3.24, marking a decrease of 3.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:42 am
| Metric | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 270 | 425 | 753 | 814 | 1,038 | 1,218 | 1,175 | 1,371 | 1,597 | 2,230 | 2,505 | 2,258 | 2,494 |
| Expenses | 205 | 340 | 630 | 703 | 887 | 1,068 | 990 | 971 | 1,321 | 2,076 | 2,258 | 2,116 | 2,247 |
| Operating Profit | 65 | 85 | 123 | 110 | 151 | 150 | 186 | 400 | 276 | 153 | 247 | 141 | 247 |
| OPM % | 24% | 20% | 16% | 14% | 15% | 12% | 16% | 29% | 17% | 7% | 10% | 6% | 10% |
| Other Income | 1 | 6 | 4 | 4 | 7 | 2 | 4 | 8 | 13 | 223 | 68 | -6 | -10 |
| Interest | 16 | 30 | 42 | 62 | 59 | 63 | 61 | 47 | 92 | 202 | 185 | 188 | 189 |
| Depreciation | 21 | 29 | 35 | 48 | 54 | 66 | 79 | 81 | 93 | 156 | 214 | 231 | 227 |
| Profit before tax | 29 | 32 | 51 | 4 | 46 | 23 | 50 | 281 | 104 | 18 | -84 | -284 | -179 |
| Tax % | 32% | 37% | 13% | 193% | 42% | 41% | 47% | 34% | 43% | 48% | -38% | -24% | |
| Net Profit | 19 | 20 | 44 | -4 | 26 | 14 | 27 | 186 | 59 | 10 | -52 | -217 | -164 |
| EPS in Rs | 2.54 | 2.58 | 5.09 | -0.38 | 2.57 | 1.33 | 2.40 | 15.88 | 5.89 | 2.31 | -3.32 | -16.05 | -12.77 |
| Dividend Payout % | 29% | 24% | 20% | -78% | 31% | 38% | 21% | 8% | 12% | 30% | -21% | 0% |
YoY Net Profit Growth
| Year | 2009-2010 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 5.26% | -109.09% | 750.00% | -46.15% | 92.86% | 588.89% | -68.28% | -83.05% | -620.00% | -317.31% |
| Change in YoY Net Profit Growth (%) | 0.00% | -114.35% | 859.09% | -796.15% | 139.01% | 496.03% | -657.17% | -14.77% | -536.95% | 302.69% |
Sagar Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2009-2010 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -254% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 26% |
| 3 Years: | 12% |
| 1 Year: | 26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | -4% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: January 7, 2026, 4:20 pm
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 17 | 20 | 20 | 20 | 22 | 24 | 24 | 26 | 26 | 26 | 26 |
| Reserves | 184 | 198 | 532 | 743 | 759 | 823 | 944 | 1,167 | 1,232 | 1,968 | 1,915 | 1,697 | 1,656 |
| Borrowings | 252 | 231 | 434 | 487 | 478 | 509 | 491 | 809 | 1,510 | 1,478 | 1,444 | 1,448 | 1,640 |
| Other Liabilities | 95 | 122 | 264 | 259 | 281 | 375 | 460 | 547 | 583 | 621 | 863 | 950 | 1,074 |
| Total Liabilities | 545 | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 4,093 | 4,248 | 4,121 | 4,396 |
| Fixed Assets | 382 | 378 | 957 | 1,001 | 1,053 | 1,244 | 1,384 | 1,301 | 2,048 | 3,168 | 3,250 | 3,109 | 3,041 |
| CWIP | 18 | 10 | 15 | 55 | 125 | 110 | 108 | 517 | 100 | 99 | 15 | 123 | 316 |
| Investments | 15 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 315 | 0 | 0 | 0 | 0 |
| Other Assets | 130 | 139 | 274 | 452 | 361 | 374 | 426 | 727 | 886 | 826 | 983 | 889 | 1,039 |
| Total Assets | 545 | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 4,093 | 4,248 | 4,121 | 4,396 |
Below is a detailed analysis of the balance sheet data for Sagar Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,656.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,697.00 Cr. (Mar 2025) to 1,656.00 Cr., marking a decrease of 41.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,640.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,448.00 Cr. (Mar 2025) to 1,640.00 Cr., marking an increase of 192.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,074.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 950.00 Cr. (Mar 2025) to 1,074.00 Cr., marking an increase of 124.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,396.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,121.00 Cr. (Mar 2025) to 4,396.00 Cr., marking an increase of 275.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,041.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,109.00 Cr. (Mar 2025) to 3,041.00 Cr., marking a decrease of 68.00 Cr..
- For CWIP, as of Sep 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2025) to 316.00 Cr., marking an increase of 193.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,039.00 Cr.. The value appears strong and on an upward trend. It has increased from 889.00 Cr. (Mar 2025) to 1,039.00 Cr., marking an increase of 150.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,396.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,121.00 Cr. (Mar 2025) to 4,396.00 Cr., marking an increase of 275.00 Cr..
Notably, the Reserves (1,656.00 Cr.) exceed the Borrowings (1,640.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -187.00 | -146.00 | -311.00 | -377.00 | -327.00 | -359.00 | -305.00 | -409.00 | 275.00 | 152.00 | 246.00 | 140.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 36 | 39 | 36 | 33 | 35 | 42 | 27 | 28 | 22 | 30 | 33 |
| Inventory Days | 200 | 209 | 241 | 386 | 239 | 222 | 186 | 189 | 338 | 241 | 273 | 232 |
| Days Payable | 136 | 150 | 353 | 516 | 344 | 312 | 358 | 349 | 358 | 267 | 460 | 490 |
| Cash Conversion Cycle | 97 | 95 | -73 | -95 | -73 | -55 | -130 | -133 | 7 | -4 | -157 | -225 |
| Working Capital Days | 61 | 40 | -57 | -46 | -46 | -59 | -61 | -2 | -45 | -36 | -59 | -108 |
| ROCE % | 12% | 14% | 6% | 8% | 7% | 8% | 18% | 8% | 6% | 1% | -2% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Smallcap Fund | 1,598,527 | 0.41 | 34.63 | 2,691,812 | 2025-12-08 00:43:19 | -40.62% |
| HDFC Multi Cap Fund | 1,473,276 | 0.16 | 31.91 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 1,460,012 | 1 | 31.63 | 1,410,872 | 2025-12-14 00:06:41 | 3.48% |
| ICICI Prudential Infrastructure Fund | 432,619 | 0.11 | 9.37 | N/A | N/A | N/A |
| SBI Comma Fund | 366,286 | 0.96 | 7.93 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 362,364 | 0.12 | 7.85 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 121,228 | 0.17 | 2.63 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | -16.58 | -3.98 | 0.66 | 5.03 | 80.24 |
| Diluted EPS (Rs.) | -16.58 | -3.98 | 0.66 | 5.03 | 80.24 |
| Cash EPS (Rs.) | 1.08 | 12.40 | 12.57 | 12.92 | 113.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 131.81 | 154.53 | 129.22 | 111.44 | 535.34 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 131.81 | 154.53 | 129.22 | 111.44 | 535.34 |
| Revenue From Operations / Share (Rs.) | 172.73 | 191.63 | 170.58 | 135.90 | 583.54 |
| PBDIT / Share (Rs.) | 12.43 | 22.96 | 28.76 | 24.61 | 173.71 |
| PBIT / Share (Rs.) | -5.22 | 6.57 | 16.84 | 16.72 | 139.43 |
| PBT / Share (Rs.) | -21.69 | -6.44 | 1.41 | 8.85 | 119.62 |
| Net Profit / Share (Rs.) | -16.58 | -3.98 | 0.65 | 5.03 | 78.98 |
| NP After MI And SOA / Share (Rs.) | -16.05 | -3.32 | 2.22 | 5.88 | 79.16 |
| PBDIT Margin (%) | 7.19 | 11.97 | 16.85 | 18.10 | 29.76 |
| PBIT Margin (%) | -3.02 | 3.43 | 9.87 | 12.30 | 23.89 |
| PBT Margin (%) | -12.55 | -3.35 | 0.82 | 6.51 | 20.49 |
| Net Profit Margin (%) | -9.59 | -2.07 | 0.38 | 3.70 | 13.53 |
| NP After MI And SOA Margin (%) | -9.29 | -1.73 | 1.30 | 4.33 | 13.56 |
| Return on Networth / Equity (%) | -12.17 | -2.23 | 1.77 | 5.50 | 15.44 |
| Return on Capital Employeed (%) | -2.29 | 2.56 | 7.20 | 7.50 | 15.91 |
| Return On Assets (%) | -5.02 | -0.99 | 0.75 | 2.05 | 7.22 |
| Long Term Debt / Equity (X) | 0.57 | 0.56 | 0.70 | 0.89 | 0.52 |
| Total Debt / Equity (X) | 0.82 | 0.74 | 0.89 | 1.20 | 0.61 |
| Asset Turnover Ratio (%) | 0.52 | 0.61 | 0.62 | 0.59 | 0.52 |
| Current Ratio (X) | 0.58 | 0.85 | 0.97 | 0.95 | 1.15 |
| Quick Ratio (X) | 0.35 | 0.55 | 0.62 | 0.67 | 0.90 |
| Inventory Turnover Ratio (X) | 7.77 | 1.59 | 1.59 | 1.72 | 1.46 |
| Dividend Payout Ratio (NP) (%) | -4.36 | -21.10 | 31.50 | 8.50 | 8.21 |
| Dividend Payout Ratio (CP) (%) | 43.65 | 5.35 | 4.95 | 3.63 | 5.73 |
| Earning Retention Ratio (%) | 104.36 | 121.10 | 68.50 | 91.50 | 91.79 |
| Cash Earning Retention Ratio (%) | 56.35 | 94.65 | 95.05 | 96.37 | 94.27 |
| Interest Coverage Ratio (X) | 0.86 | 1.62 | 1.86 | 3.13 | 8.77 |
| Interest Coverage Ratio (Post Tax) (X) | -0.01 | 0.63 | 1.04 | 1.64 | 4.99 |
| Enterprise Value (Cr.) | 3682.52 | 3981.14 | 3785.92 | 4295.75 | 2217.77 |
| EV / Net Operating Revenue (X) | 1.63 | 1.59 | 1.70 | 2.69 | 1.62 |
| EV / EBITDA (X) | 22.66 | 13.27 | 10.07 | 14.85 | 5.43 |
| MarketCap / Net Operating Revenue (X) | 1.04 | 1.09 | 1.11 | 1.82 | 1.22 |
| Retention Ratios (%) | 104.36 | 121.10 | 68.49 | 91.49 | 91.78 |
| Price / BV (X) | 1.36 | 1.40 | 1.51 | 2.31 | 1.39 |
| Price / Net Operating Revenue (X) | 1.04 | 1.09 | 1.11 | 1.82 | 1.22 |
| EarningsYield | -0.08 | -0.01 | 0.01 | 0.02 | 0.11 |
After reviewing the key financial ratios for Sagar Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 5. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For Diluted EPS (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 5. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 3. It has decreased from 12.40 (Mar 24) to 1.08, marking a decrease of 11.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.81. It has decreased from 154.53 (Mar 24) to 131.81, marking a decrease of 22.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.81. It has decreased from 154.53 (Mar 24) to 131.81, marking a decrease of 22.72.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.73. It has decreased from 191.63 (Mar 24) to 172.73, marking a decrease of 18.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.43. This value is within the healthy range. It has decreased from 22.96 (Mar 24) to 12.43, marking a decrease of 10.53.
- For PBIT / Share (Rs.), as of Mar 25, the value is -5.22. This value is below the healthy minimum of 0. It has decreased from 6.57 (Mar 24) to -5.22, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is -21.69. This value is below the healthy minimum of 0. It has decreased from -6.44 (Mar 24) to -21.69, marking a decrease of 15.25.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 2. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -16.05. This value is below the healthy minimum of 2. It has decreased from -3.32 (Mar 24) to -16.05, marking a decrease of 12.73.
- For PBDIT Margin (%), as of Mar 25, the value is 7.19. This value is below the healthy minimum of 10. It has decreased from 11.97 (Mar 24) to 7.19, marking a decrease of 4.78.
- For PBIT Margin (%), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 10. It has decreased from 3.43 (Mar 24) to -3.02, marking a decrease of 6.45.
- For PBT Margin (%), as of Mar 25, the value is -12.55. This value is below the healthy minimum of 10. It has decreased from -3.35 (Mar 24) to -12.55, marking a decrease of 9.20.
- For Net Profit Margin (%), as of Mar 25, the value is -9.59. This value is below the healthy minimum of 5. It has decreased from -2.07 (Mar 24) to -9.59, marking a decrease of 7.52.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -9.29. This value is below the healthy minimum of 8. It has decreased from -1.73 (Mar 24) to -9.29, marking a decrease of 7.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is -12.17. This value is below the healthy minimum of 15. It has decreased from -2.23 (Mar 24) to -12.17, marking a decrease of 9.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.29. This value is below the healthy minimum of 10. It has decreased from 2.56 (Mar 24) to -2.29, marking a decrease of 4.85.
- For Return On Assets (%), as of Mar 25, the value is -5.02. This value is below the healthy minimum of 5. It has decreased from -0.99 (Mar 24) to -5.02, marking a decrease of 4.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.57. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 0.57, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.82. This value is within the healthy range. It has increased from 0.74 (Mar 24) to 0.82, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has decreased from 0.61 (Mar 24) to 0.52, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1.5. It has decreased from 0.85 (Mar 24) to 0.58, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.35, marking a decrease of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.77. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 7.77, marking an increase of 6.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -4.36. This value is below the healthy minimum of 20. It has increased from -21.10 (Mar 24) to -4.36, marking an increase of 16.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 43.65. This value is within the healthy range. It has increased from 5.35 (Mar 24) to 43.65, marking an increase of 38.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 104.36. This value exceeds the healthy maximum of 70. It has decreased from 121.10 (Mar 24) to 104.36, marking a decrease of 16.74.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 56.35. This value is within the healthy range. It has decreased from 94.65 (Mar 24) to 56.35, marking a decrease of 38.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 1.62 (Mar 24) to 0.86, marking a decrease of 0.76.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 3. It has decreased from 0.63 (Mar 24) to -0.01, marking a decrease of 0.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,682.52. It has decreased from 3,981.14 (Mar 24) to 3,682.52, marking a decrease of 298.62.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.63, marking an increase of 0.04.
- For EV / EBITDA (X), as of Mar 25, the value is 22.66. This value exceeds the healthy maximum of 15. It has increased from 13.27 (Mar 24) to 22.66, marking an increase of 9.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.04, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 104.36. This value exceeds the healthy maximum of 70. It has decreased from 121.10 (Mar 24) to 104.36, marking a decrease of 16.74.
- For Price / BV (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.36, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.04, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is -0.08. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.08, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sagar Cements Ltd:
- Net Profit Margin: -9.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.29% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -12.17% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 37.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.82
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.59%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Plot No. 111, Hyderabad Telangana 500033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K V Vishnu Raju | Chairman & Ind.Director |
| Dr. S Anand Reddy | Managing Director |
| Mr. S Sreekanth Reddy | Joint Managing Director |
| Mrs. S Rachana | Non Executive Director |
| Mrs. O Rekha | Independent Director |
| Mr. Ravichandran Rajagopal | Independent Director |
| Mr. Madhavan Ganesan | Nominee Director |
| Mrs. N Sudha Rani | Nominee Director |
| Mr. Jens Van Nieuwenborgh | Nominee Director |
FAQ
What is the intrinsic value of Sagar Cements Ltd?
Sagar Cements Ltd's intrinsic value (as of 09 January 2026) is ₹162.63 which is 21.43% lower the current market price of ₹207.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,704 Cr. market cap, FY2025-2026 high/low of ₹300/155, reserves of ₹1,656 Cr, and liabilities of ₹4,396 Cr.
What is the Market Cap of Sagar Cements Ltd?
The Market Cap of Sagar Cements Ltd is 2,704 Cr..
What is the current Stock Price of Sagar Cements Ltd as on 09 January 2026?
The current stock price of Sagar Cements Ltd as on 09 January 2026 is ₹207.
What is the High / Low of Sagar Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sagar Cements Ltd stocks is ₹300/155.
What is the Stock P/E of Sagar Cements Ltd?
The Stock P/E of Sagar Cements Ltd is .
What is the Book Value of Sagar Cements Ltd?
The Book Value of Sagar Cements Ltd is 129.
What is the Dividend Yield of Sagar Cements Ltd?
The Dividend Yield of Sagar Cements Ltd is 0.00 %.
What is the ROCE of Sagar Cements Ltd?
The ROCE of Sagar Cements Ltd is 2.19 %.
What is the ROE of Sagar Cements Ltd?
The ROE of Sagar Cements Ltd is 10.3 %.
What is the Face Value of Sagar Cements Ltd?
The Face Value of Sagar Cements Ltd is 2.00.